Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
1.365
+0.255 (22.97%)
At close: Sep 29, 2026, 4:00 PM EDT
1.460
+0.095 (6.96%)
Pre-market: Sep 30, 2026, 4:03 AM EDT
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $173.7 million as of September 29, 2026. Its market cap has increased by 65.93% in one year.
Market Cap
173.70M
Enterprise Value
117.49M
1-Year Change
65.93%
Ranking
Category
Stock Price
$1.37
ChartMarket Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has increased from $117.04M to $173.70M, an increase of 48.42%. That is a compound annual growth rate of 7.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 173.07M | -29.73% |
| Dec 31, 2025 | 246.29M | 16.76% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Unicycive Therapeutics | 130.78M |
| Tiziana Life Sciences | 130.60M |
| NRx Pharmaceuticals | 129.57M |
| Immunic | 127.51M |
| Neumora Therapeutics | 127.32M |
| MediciNova | 126.99M |
| LENZ Therapeutics | 123.01M |
| Inovio Pharmaceuticals | 122.01M |